Page last updated: 2024-09-04

levofloxacin and Tuberculosis, Drug-Resistant

levofloxacin has been researched along with Tuberculosis, Drug-Resistant in 101 studies

Research

Studies (101)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (2.97)18.2507
2000's13 (12.87)29.6817
2010's59 (58.42)24.3611
2020's26 (25.74)2.80

Authors

AuthorsStudies
Guo, H; Li, L; Liu, M; Lu, Y; Shen, W; Wang, B; Wang, M; Zhang, R; Zhang, T1
Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D1
Chopra, S; Choudhari, AS; Dusthackeer, VNA; Gaikwad, VR; Karale, UB; Krishna, EV; Krishna, VS; Mahizhaveni, B; Misra, S; Rode, HB; Sarkar, D; Shukla, M; Sriram, D1
Batt, SM; Besra, GS; Fu, L; Huang, H; Li, G; Lu, Y; Qin, R; Wang, B; Wang, P; Wang, Y; Wu, C1
Chopra, S; Dasgupta, A; Kaul, G; Kumar Sahoo, S; Maddipatla, S; Madhavi Yaddanapudi, V; Nageswara Rao Gajula, S; Naiyaz Ahmad, M; Nanduri, S; Sonti, R1
Blackman, A; Cáceres, T; Cachay, R; Gotuzzo, E; Maruri, F; Meza, E; Schwalb, A; Sterling, TR1
Leung, PKL; Ng, KKM; Yip, PCW1
Chen, X; Fu, L; Gao, T; Huo, F; Li, Q; Lu, Y; Pang, Y; Wang, B; Zhang, X1
Jiang, H; Li, X; Niu, Q; Xing, Z; Xu, J1
Dodd, PJ; Mafirakureva, N; McQuaid, CF; Seddon, JA1
Garcia-Prats, AJ; Hesseling, AC; Hoddinott, G; Purchase, SE; Reis, R; Reynolds, LJ; Seddon, JA; Wademan, DT1
Cachay, R; Diacon, AH; Gotuzzo, E; Horsburgh, CR; Kaur, P; Mitnick, CD; Phillips, PPJ; Schwalb, A; Sterling, TR; Ugarte-Gil, C; Wright, A1
Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN1
Gao, J; Gao, M; Li, L; Liu, F; Liu, Y; Pang, Y; Shu, W; Sun, Y; Xie, L; Zhang, L1
Hsiao, HC; Jou, R; Wu, SH; Xiao, YX1
Brankin, A; Colman, RE; Georghiou, SB; Seifert, M; Suresh, A; Uplekar, S; Walker, TM1
Ahn, JH; Cho, SN; Hahn, S; Jeon, D; Jhun, BW; Jo, KW; Kang, YA; Kim, DK; Kim, J; Kim, JS; Kim, K; Kim, S; Kim, SY; Kim, YR; Kwak, N; Lee, JK; Lee, JY; Lee, M; Lee, SH; Lee, T; Mok, J; Park, JS; Seok, KH; Shim, TS; Yim, D; Yim, JJ; Yoon, S1
An, Q; Lin, R; Wang, C; Wang, D; Yang, Q1
Ali, AM; Draper, HR; Fourie, B; Garcia-Prats, AJ; Hesseling, AC; Hughes, J; Nielsen, J; Radtke, KK; Savic, RM; Schaaf, HS; Solans, BP; van der Laan, L; Winckler, J1
Aung, KJM; Decroo, T; Kuaban, C; Noeske, J; Piubello, A; Rieder, HL; Van Deun, A1
Behr, MA; Benedetti, A; Britton, WJ; Dowdy, DW; Fox, GJ; Graham, SM; Marais, BJ; Marks, GB; Mason, P; Menzies, D; Nguyen, BH; Nguyen, CB; Nguyen, TA; Nguyen, VN; Tran, PT; Velen, K1
Erber, J; Rothe, K; Schmid, RM; Schneider, J; Spinner, CD; Tschaikowsky, T; Weidlich, S1
Ghazvini, K; Hashemy, SI; Hoffner, S; Jamedar, SA; Meshkat, Z; Sayadi, M; Soleimanpour, S; Zare, H1
Dong, L; Huo, F; Li, S; Li, Y; Ma, Y; Pang, Y; Shang, Y; Xue, Y1
E R, V; Keny, S; Lawande, D; Parrikar, A1
Baloch, AQ; Ghazal, A; Khanzada, FM; Mustafa, T; Qadir, M; Rizvi, AH; Tahseen, S1
Eather, G; Matigian, N; O'Connor, B; Wilson, M1
Alffenaar, JW; Bruchfeld, J; Davies Forsman, L; Eliasson, E; Hoffner, S; Hong, C; Hu, Y; Ke, R; Kuhlin, J; Niward, K; Paues, J; Schön, T; Simonsson, USH; Werngren, J; Xu, B; Zheng, R; Zheng, X1
Qiujing, F; Weiwei, W1
Davies, GR; Peloquin, CA1
Mamatha, HG; Shanthi, V1
Aono, A; Chikamatsu, K; Igarashi, Y; Mitarai, S; Takaki, A; Yamada, H; Yi, L1
Andres, S; Beckert, P; Heyckendorf, J; Hillemann, D; Kohl, TA; Köser, CU; Lange, C; Merker, M; Moradigaravand, D; Niemann, S; Olaru, ID; Parkhill, J; Peacock, SJ; Schleusener, V; Schön, T; Sturegård, E1
Denti, P; Dooley, KE; Draper, HR; Garcia-Prats, AJ; Hesseling, AC; McIlleron, HM; Savic, RM; Schaaf, HS; Thee, S; Wiesner, L; Winckler, J1
Bastos, ML; Bertolde, AI; Cosme, LB; Dalcolmo, MP; do Prado, TN; Fregona, G; Kritski, A; Maciel, ELN; Sanchez, MN; Trajman, A; Zandonade, E1
Bouton, TC; Butler, D; Diacon, AH; Dianis, N; Eisenach, K; Gandhi, NR; Gotuzzo, E; Horsburgh, CR; Hunt, KR; Lecca, L; Martel, B; Mitnick, CD; Moreno-Martinez, A; Patientia, RF; Peloquin, CA; Phillips, PPJ; Santillan, J; Seas, C; Vargas, D; von Groote-Bidlingmaier, F1
Behera, D; Kaur, P; Saini, A; Sethi, S; Yadav, R1
Burger, A; Draper, HR; Finlayson, H; Fourie, B; Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS; Thee, S; Winckler, J1
Aktoğu Özkan, S; Biçmen, C; Çavuşoğlu, C; Eraç, B; Ermertcan, Ş; Hoşgör Limoncu, M; Yılmaz, FF1
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y1
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M1
Bantubani, N; Chotoo, S; Conradie, F; Enwerem, M; Ferreira, H; Hughes, J; Ismail, N; Maartens, G; Master, I; Meintjes, G; Mohr, E; Ndjeka, N; Padanilam, X; Romero, R; Schnippel, K; Singh, N; Te Riele, J; Variava, E1
Bendet, P; Deshpande, D; Gumbo, T; Heysell, SK; Koeuth, T; Lee, PS; Mpagama, SG; Pasipanodya, JG; Srivastava, S1
Ambrose, PG; Bendet, P; Bhavnani, SM; Deshpande, D; Gumbo, T; Heysell, SK; Koeuth, T; Lee, PS; Mpagama, SG; Pasipanodya, JG; Srivastava, S; Thwaites, G1
Alarcón Guizado, VA; Alarcon, E; Cornejo Garcia, JG; Heldal, E; Mendoza Ticona, A; Moore, DAJ1
De Koker, P; Draper, HR; Garcia-Prats, AJ; Hesseling, AC; Osman, M; Purchase, SE; Schaaf, HS; Seddon, JA1
Crook, AM; Demers, AM; Fairlie, L; Garcia-Prats, AJ; Gibb, DM; Hesseling, AC; Hoddinott, G; Martinson, N; Osman, M; Owen-Powell, E; Purchase, SE; Schaaf, HS; Seddon, JA; Thomason, MJ; Turkova, A1
Ahn, H; Ahn, JH; Cho, SN; Hahn, S; Jang, JY; Jeon, D; Jhun, BW; Jo, KW; Kang, YA; Kim, CK; Kim, DK; Kim, JS; Kim, SY; Kim, YR; Koh, WJ; Lee, JH; Lee, JY; Lee, M; Lee, SH; Lee, T; Mok, J; Park, JS; Shim, TS; Shin, S; Shin, SJ; Song, T; Won, HJ; Yim, JJ1
Alffenaar, JC; Ghimire, GR; Ghimire, S; Jongedijk, EM; Kosterink, JGW; Maharjan, B; Shrestha, B; Touw, DJ; van der Werf, TS1
Denti, P; Draper, HR; Garcia-Prats, AJ; Hesseling, AC; Osman, M; Purchase, SE; Schaaf, HS; Wiesner, L1
Alvarez-Cabrera, N; Blanc, L; Dartois, V; Dias-Freedman, I; Dietzold, J; Ho Liang, HP; Kaya, F; Kirschner, D; Linderman, J; Mina, M; O'Brien, P; Pienaar, E; Prideaux, B; Salgame, P; Sarathy, J; Savic, RM; Zimmerman, M1
Amanullah, F; Becerra, MC; Brooks, MB; Fuad, J; Hussain, H; Jaswal, M; Malik, AA; Peloquin, CA; Siddiqui, S; Yuen, CM1
Ahmed, S; Al-Shaer, MH; Alghamdi, WA; Alkabab, Y; Alsultan, A; An, G; Banu, S; Barbakadze, K; Cegielski, JP; Heysell, SK; Houpt, E; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA1
Ader, F; Collardeau-Frachon, S; Gillet, Y; Huguet, A; Ohlmann, C1
Abbara, A; Abubakar, I; Alexander, E; Booth, H; Bothamley, GH; Creer, DD; Davidson, JA; Harris, RJ; Kon, OM; Kunst, H; Lalor, MK; Lipman, MC; Loebinger, MR; Loutet, MG; Lozewicz, S; McHugh, TD; Milburn, HJ; Mohiyuddin, T; Palchaudhuri, P; Phillips, PPJ; Schmok, E; Stagg, HR; Taylor, L1
Ahmed, I; Hasan, R; Inayat, R; Jabeen, K1
Jiang, RH; Li, L; Xu, HB1
Davies, GR; Titarenko, AF; Ziganshina, LE1
Cataldi, AA; Di Giulio, AB; Imperiale, BR; Morcillo, NS; Zumárraga, MJ1
Chan Kim, K; Choi, JC; Choi, SB; Choi, WI; Heo, EY; Hwang, YI; Jang, SH; Jeon, K; Jung, KH; Kang, YA; Ki, YW; Kim, KU; Kim, SJ; Kim, YH; Koh, WJ; Kwon, YS; Lee, CH; Lee, J; Lee, JH; Lee, SH; Lee, YS; Ryu, YJ; Shim, TS; Um, S; Yim, JJ; Yoo, KH1
Schluger, NW1
Caleffi-Ferracioli, KR; Cardoso, RF; Maltempe, FG; Siqueira, VL1
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S1
Behera, C; Krishna, K; Singh, HR1
Adler-Shohet, FC; Carson, M; Girma, H; Low, J; Singh, J1
Castel, S; Draper, HR; Garcia-Prats, AJ; Hesseling, AC; McIlleron, HM; Norman, J; Schaaf, HS; Thee, S; van der Merwe, PL; Wiesner, L1
Jeong, BH; Koh, WJ; Kwon, YS1
Alvarez, N; Araque, P; Mejía, GI; Peláez, C; Realpe, T; Robledo, J; Rouzaud, F; Zapata, E1
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V1
Bablishvili, N; Barth, AB; Blumberg, HM; Derendorf, H; Gogishvili, S; Guarner, J; Kempker, RR; Nikolaishvili, K; Peloquin, CA; Sabulua, I; Singh, RS; Tukvadze, N; Vashakidze, S1
Donald, PR; Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS; Thee, S1
Alsultan, A; An, G; Peloquin, CA1
Ader, F; Bouaziz, A; Catho, G; Dumitriescu, O; Pedone, C; Perpoint, T; Reix, P; Ronnaux-Baron, AS; Sénéchal, A; Valour, F1
Huh, HJ; Jeon, K; Jeong, BH; Koh, WJ; Lee, H; Lee, NY; Park, HY1
Bamrah Morris, S; Brostrom, R; Chorba, T; Daley, CL; Fred, D; Gonzalez, D; Jereb, JA; Loeffler, AM; Martin, F; Mase, SR; Menon, LR; Peloquin, CA1
Bae, DW; Cho, SN; Dartois, V; Desta, KT; Eum, SY; Lee, SJ; Shin, SC1
Choi, JC; Choi, SB; Choi, WI; Heo, E; Hwang, YI; Jang, SH; Jeon, K; Jung, KH; Kang, YA; Kim, KC; Kim, KU; Kim, SJ; Kim, YH; Koh, WJ; Kwon, YS; Lee, CH; Lee, HK; Lee, JH; Lee, SH; Ryu, YJ; Shim, TS; Um, S; Yim, JJ; Yoo, KH1
Baboolal, SO; Garcia-Prats, AJ; Hesseling, AC; Mohamed, N; Schaaf, HS; Solomons, R; van der Laan, LE; van Toorn, R; Willemse, M1
Akkerman, OW; Alffenaar, JW; de Lange, WC; Ghimire, S; Kosterink, JG; Touw, DJ; van der Werf, TS; van Soolingen, D; Van't Boveneind-Vrubleuskaya, N; Wilffert, B1
Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA1
Ebers, A; Heysell, S; Kisonga, R; Lekule, I; Liu, J; Mpagama, S; Stroup, S1
Sterling, TR1
Chan, RC; Chang, KC; Yew, WW1
Chung, HS; Han, SK; Kim, DK; Kim, JY; Kim, YW; Lee, CH; Lee, CT; Lee, J; Lee, JH; Lee, SM; Yang, SC; Yim, JJ; Yoo, CG; Yoon, HI1
Bourdon, O; Chauny, JV; De Lauzanne, A; Doit, C; Géréral, T; Lorrot, M; Prot-Labarthe, S1
Dolovich, LR; Holbrook, A; Loeb, M; Papastavros, T; Whitehead, L1
Covi, M; Fabbri, LM; Ferrara, G; Franco, F; Meschiari, E; Richeldi, L; Vailati, P; Velluti, G1
Chen, L; Chen, QL; Yin, JJ1
Chan, CK; Chau, CH; Lee, J; Leung, CC; Tam, CM; Wong, PC; Yew, WW2
Li, SM; Xing, BC; Zheng, XM1
Squire, SB; Vizel, AA; Ziganshina, LE1
Hirano, A; Kawata, N; Kimura, G; Okada, C; Shibayama, T; Soda, R; Tada, A; Takahashi, K; Takahashi, S; Takeuchi, M1
Squire, SB; Ziganshina, LE1
Cohen, C; de Gouveia, L; du Plessis, M; Govender, N; Hoffmann, R; Klugman, KP; Meiring, S; Mpembe, R; Quan, V; Schrag, S; Smith, AM; von Gottberg, A; Whitelaw, A; Wolter, N1
Au, KF; Chau, CH; Lee, J; Yew, WW1
Berning, SE; Huitt, GA; Iseman, MD; Peloquin, CA1
Benson, CA; Chirgwin, KD; El-Sadr, WM; Matts, JP; Nelson, ET; Perlman, DC; Sepkowitz, KA; Telzak, EE1
Berning, SE; Cherry, TA; Iseman, MD1
Hoeppner, V; Marciniuk, D; Peloquin, CA; Reid, J1
Angkananukool, K; Pracharktam, R; Vibhagool, A1

Reviews

11 review(s) available for levofloxacin and Tuberculosis, Drug-Resistant

ArticleYear
Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis.
    Journal of global antimicrobial resistance, 2023, Volume: 34

    Topics: Antitubercular Agents; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Mycobacterium tuberculosis; Phenotype; Tuberculosis, Multidrug-Resistant

2023
The Treatment of Tuberculosis.
    Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:6

    Topics: Animals; Antitubercular Agents; Drug Monitoring; Drug Therapy, Combination; Humans; Isoniazid; Levofloxacin; Rifampin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant

2021
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet (London, England), 2018, 09-08, Volume: 392, Issue:10150

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2018
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
    The Cochrane database of systematic reviews, 2013, Jun-06, Issue:6

    Topics: Antitubercular Agents; Ciprofloxacin; Drug Substitution; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2013
Tuberculosis: clinical trials and new drug regimens.
    Current opinion in pulmonary medicine, 2014, Volume: 20, Issue:3

    Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant

2014
Fluoroquinolones for the treatment of tuberculosis in children.
    Tuberculosis (Edinburgh, Scotland), 2015, Volume: 95, Issue:3

    Topics: Age Factors; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2015
[Children exposed to multidrug-resistant tuberculosis: How should we manage? Analysis of 46 child contacts and review of the literature].
    Revue de pneumologie clinique, 2015, Volume: 71, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; France; Humans; Infant; Latent Tuberculosis; Levofloxacin; Lost to Follow-Up; Male; Tuberculosis, Multidrug-Resistant

2015
Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Child; Clinical Trials as Topic; Extensively Drug-Resistant Tuberculosis; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2016
Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:8

    Topics: Antitubercular Agents; Aza Compounds; Bacterial Proteins; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genotype; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant

2010
Fluoroquinolones for treating tuberculosis.
    The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3

    Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2005
Fluoroquinolones for treating tuberculosis.
    The Cochrane database of systematic reviews, 2008, Jan-23, Issue:1

    Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2008

Trials

12 trial(s) available for levofloxacin and Tuberculosis, Drug-Resistant

ArticleYear
Factors associated with screening failure and study withdrawal in multidrug-resistant TB.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022, 09-01, Volume: 26, Issue:9

    Topics: Antitubercular Agents; Humans; Levofloxacin; Mycobacterium tuberculosis; South Africa; Sputum; Tuberculosis, Multidrug-Resistant

2022
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in So
    Lancet (London, England), 2022, 10-29, Volume: 400, Issue:10362

    Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2022
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial.
    BMJ open, 2020, 01-02, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Latent Tuberculosis; Levofloxacin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vietnam; Young Adult

2020
An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.
    Trials, 2017, Nov-25, Volume: 18, Issue:1

    Topics: Antitubercular Agents; Clinical Protocols; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2017
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
    PloS one, 2018, Volume: 13, Issue:12

    Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Isoniazid; Levofloxacin; Male; Middle Aged; Peru; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Time Factors; Tuberculosis, Multidrug-Resistant

2018
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).
    Trials, 2018, Dec-20, Volume: 19, Issue:1

    Topics: Age Factors; Antitubercular Agents; Child, Preschool; Clinical Trials, Phase III as Topic; Contact Tracing; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Female; Housing; Humans; Infant; Levofloxacin; Male; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; South Africa; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2018
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, m
    Trials, 2019, Jan-16, Volume: 20, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Humans; Levofloxacin; Linezolid; Male; Middle Aged; Multicenter Studies as Topic; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Republic of Korea; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2019
Pharmacokinetics, Safety, and Dosing of Novel Pediatric Levofloxacin Dispersible Tablets in Children with Multidrug-Resistant Tuberculosis Exposure.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:4

    Topics: Antitubercular Agents; Biological Availability; Child, Preschool; Female; Humans; Infant; Levofloxacin; Male; Placebos; Tablets; Tuberculosis, Multidrug-Resistant

2019
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
    American journal of respiratory and critical care medicine, 2013, Oct-01, Volume: 188, Issue:7

    Topics: Adult; Aged; Antitubercular Agents; Aza Compounds; Fluoroquinolones; Humans; Levofloxacin; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Republic of Korea; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2013
Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6

    Topics: Adolescent; Adult; Antitubercular Agents; Female; Humans; Levofloxacin; Male; Middle Aged; Tuberculosis, Multidrug-Resistant; Young Adult

2015
Choice between Levofloxacin and Moxifloxacin and Multidrug-Resistant Tuberculosis Treatment Outcomes.
    Annals of the American Thoracic Society, 2016, Volume: 13, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Moxifloxacin; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Republic of Korea; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2016
[Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis].
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:5

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminosalicylic Acid; Aminosalicylic Acids; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2004

Other Studies

78 other study(ies) available for levofloxacin and Tuberculosis, Drug-Resistant

ArticleYear
Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
    European journal of medicinal chemistry, 2015, Nov-02, Volume: 104

    Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrrolidines; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant

2015
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
    European journal of medicinal chemistry, 2019, Feb-15, Volume: 164

    Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2019
Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
    European journal of medicinal chemistry, 2019, Sep-15, Volume: 178

    Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles; Tuberculosis, Multidrug-Resistant

2019
Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.
    European journal of medicinal chemistry, 2022, Mar-05, Volume: 231

    Topics: Animals; Antitubercular Agents; Benzenesulfonamides; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfonamides; Thiophenes; Tuberculosis, Multidrug-Resistant

2022
Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.
    Bioorganic & medicinal chemistry, 2022, 06-15, Volume: 64

    Topics: Amines; Animals; Antitubercular Agents; Benzoxazoles; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vero Cells

2022
Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru.
    BMC research notes, 2021, Nov-14, Volume: 14, Issue:1

    Topics: Antitubercular Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Peru; Pharmaceutical Preparations; Tuberculosis; Tuberculosis, Multidrug-Resistant

2021
Prevalences of levofloxacin resistance and
    Hong Kong medical journal = Xianggang yi xue za zhi, 2021, Volume: 27, Issue:6

    Topics: Amidohydrolases; Antitubercular Agents; Hong Kong; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Prevalence; Tuberculosis, Multidrug-Resistant

2021
Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in
    Microbial drug resistance (Larchmont, N.Y.), 2022, Volume: 28, Issue:3

    Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA Gyrase; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Tuberculosis, Multidrug-Resistant

2022
Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant
    Current drug delivery, 2023, Volume: 20, Issue:3

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Levofloxacin; Linezolid; Mycobacterium tuberculosis; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Prothionamide; Pyrazinamide; Reactive Oxygen Species; Tuberculosis; Tuberculosis, Multidrug-Resistant

2023
The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study.
    The Lancet. Global health, 2022, Volume: 10, Issue:7

    Topics: Adult; Antitubercular Agents; Child; HIV Infections; Humans; Levofloxacin; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant

2022
Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children.
    PloS one, 2022, Volume: 17, Issue:7

    Topics: Antitubercular Agents; Caregivers; Child, Preschool; Humans; Levofloxacin; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2022
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
    BMC infectious diseases, 2022, Aug-24, Volume: 22, Issue:1

    Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant

2022
Development and Validation of a Nomogram for Prediction of QT Interval Prolongation in Patients Administered Bedaquiline-Containing Regimens in China: a Modeling Study.
    Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9

    Topics: Antitubercular Agents; Clofazimine; Creatinine; Diarylquinolines; Humans; Levofloxacin; Long QT Syndrome; Moxifloxacin; Nomograms; Tuberculosis, Multidrug-Resistant

2022
Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs.
    Microbiology spectrum, 2022, 12-21, Volume: 10, Issue:6

    Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant

2022
In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis.
    Scientific reports, 2022, 10-22, Volume: 12, Issue:1

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Genotype; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization

2022
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies.
    Antimicrobial agents and chemotherapy, 2023, 07-18, Volume: 67, Issue:7

    Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Clofazimine; Electrocardiography; Humans; Levofloxacin; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant

2023
Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2019, 09-01, Volume: 23, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bangladesh; Cameroon; Child; Drug Administration Schedule; Female; Gatifloxacin; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Niger; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2019
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
    BMC infectious diseases, 2020, May-24, Volume: 20, Issue:1

    Topics: Amikacin; Antitubercular Agents; Diarylquinolines; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Macrolides; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Soft Tissue Injuries; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult

2020
Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
    BMC infectious diseases, 2020, Jun-01, Volume: 20, Issue:1

    Topics: Antitubercular Agents; Codon; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Genotype; Humans; Iran; Levofloxacin; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Multidrug-Resistant

2020
Specific gyrA Gene Mutations Correlate with High Prevalence of Discordant Levofloxacin Resistance in Mycobacterium tuberculosis Isolates from Beijing, China.
    The Journal of molecular diagnostics : JMD, 2020, Volume: 22, Issue:9

    Topics: Antitubercular Agents; Beijing; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Prevalence; Retrospective Studies; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2020
Gitelman-like syndrome: A rare complication of using aminoglycosides in tuberculosis - A case report.
    The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3

    Topics: Alkalosis; Antitubercular Agents; Capreomycin; Clofazimine; Cycloserine; Deprescriptions; Ethionamide; Gitelman Syndrome; Humans; Hypocalcemia; Hypokalemia; Levofloxacin; Linezolid; Male; Middle Aged; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Water-Electrolyte Imbalance

2020
Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
    PloS one, 2020, Volume: 15, Issue:9

    Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Genotype; Humans; Infant; Isoniazid; Laboratories; Levofloxacin; Male; Microbial Sensitivity Tests; Pakistan; Phenotype; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult

2020
Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case series.
    Respiratory medicine, 2020, Volume: 173

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Australia; Child; Child, Preschool; Drug Therapy, Combination; Ethambutol; Ethinyl Estradiol-Norgestrel Combination; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2020
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.
    The European respiratory journal, 2021, Volume: 57, Issue:3

    Topics: Antitubercular Agents; China; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pharmaceutical Preparations; Prospective Studies; Tuberculosis, Multidrug-Resistant

2021
Efficacy of moxifloxacin combined with levofloxacin in the treatment of drug-resistant tuberculosis.
    Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:3(Special)

    Topics: Adult; Antibiotics, Antitubercular; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Random Allocation; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2020
Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
    Journal of global antimicrobial resistance, 2018, Volume: 12

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; India; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Prospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult

2018
Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
    Diagnostic microbiology and infectious disease, 2017, Volume: 89, Issue:4

    Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Seoul; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2017
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2

    Topics: Antitubercular Agents; Bacterial Typing Techniques; Cohort Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genome, Bacterial; Genotype; Humans; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing

2018
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Area Under Curve; Child; Child, Preschool; Coinfection; Drug Administration Schedule; Drug Dosage Calculations; Female; HIV; HIV Infections; Humans; Infant; Levofloxacin; Male; Models, Statistical; Mycobacterium tuberculosis; Prospective Studies; South Africa; Tablets; Tuberculosis, Multidrug-Resistant

2018
Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.
    BMC infectious diseases, 2017, 11-14, Volume: 17, Issue:1

    Topics: Adult; Antitubercular Agents; Brazil; Cohort Studies; Female; Humans; Levofloxacin; Male; Middle Aged; Recurrence; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2017
Diagnostic accuracy of GenoType
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 04-01, Volume: 22, Issue:4

    Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; India; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2018
Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-13, Volume: 67, Issue:11

    Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Female; Heart; Humans; Levofloxacin; Male; Prospective Studies; South Africa; Time Factors; Tuberculosis, Multidrug-Resistant

2018
In vitro effects of ciprofloxacin, levofloxacin and moxifloxacin on Mycobacterium tuberculosis isolates.
    Tuberkuloz ve toraks, 2018, Volume: 66, Issue:1

    Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant; Turkey

2018
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9

    Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2019
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen.
    The European respiratory journal, 2018, Volume: 52, Issue:6

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; HIV Infections; Humans; Levofloxacin; Linezolid; Male; Middle Aged; Poisson Distribution; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2018
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-28, Volume: 67, Issue:suppl_3

    Topics: Antitubercular Agents; Ethionamide; Humans; Isoniazid; Levofloxacin; Monte Carlo Method; Mutation; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2018
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-28, Volume: 67, Issue:suppl_3

    Topics: Algorithms; Antitubercular Agents; Artificial Intelligence; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2018
Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant Tuberculosis.
    The Pediatric infectious disease journal, 2019, Volume: 38, Issue:6

    Topics: Antitubercular Agents; Child, Preschool; Drug Compounding; Female; Humans; Infant; Levofloxacin; Male; South Africa; Tablets; Tuberculosis, Multidrug-Resistant

2019
Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients.
    The European respiratory journal, 2019, Volume: 53, Issue:4

    Topics: Humans; Levofloxacin; Prospective Studies; Tuberculosis, Multidrug-Resistant

2019
Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5

    Topics: Animals; Antitubercular Agents; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Rabbits; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant

2019
Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5

    Topics: Antitubercular Agents; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pakistan; Tuberculosis, Multidrug-Resistant

2019
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Moxifloxacin; Ofloxacin; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2019
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.
    The Pediatric infectious disease journal, 2019, Volume: 38, Issue:10

    Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Latent Tuberculosis; Levofloxacin; Male; Massive Hepatic Necrosis; Pyrazinamide; Tuberculosis, Multidrug-Resistant

2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.
    The European respiratory journal, 2019, Volume: 54, Issue:4

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Logistic Models; London; Male; Middle Aged; Practice Guidelines as Topic; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Treatment Failure; Tuberculosis, Multidrug-Resistant; World Health Organization; Young Adult

2019
Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Pakistan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2013
Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Aza Compounds; China; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Recurrence; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2013
Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:8

    Topics: Antitubercular Agents; Argentina; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifampin; Sequence Analysis, DNA; Tuberculosis; Tuberculosis, Multidrug-Resistant

2013
Fluoroquinolones in the treatment of tuberculosis: which is best?
    American journal of respiratory and critical care medicine, 2013, Oct-01, Volume: 188, Issue:7

    Topics: Aza Compounds; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Quinolines; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2013
Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
    Tuberculosis (Edinburgh, Scotland), 2013, Volume: 93, Issue:6

    Topics: Antitubercular Agents; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Oxazines; Tuberculosis; Tuberculosis, Multidrug-Resistant; Xanthenes

2013
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2014
Antitubercular drug-induced violent suicide of a hospitalised patient.
    BMJ case reports, 2014, Jan-06, Volume: 2014

    Topics: Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Ethambutol; Heart Injuries; Hospitalization; Humans; India; Levofloxacin; Male; Psychoses, Substance-Induced; Self-Injurious Behavior; Suicide; Tuberculosis, Multidrug-Resistant; Violence; Wounds, Stab; Young Adult

2014
Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.
    The Pediatric infectious disease journal, 2014, Volume: 33, Issue:6

    Topics: Adolescent; Antibiotic Prophylaxis; Antitubercular Agents; Child; Contact Tracing; Humans; Latent Tuberculosis; Levofloxacin; Pyrazinamide; Retrospective Studies; Tuberculosis, Multidrug-Resistant

2014
Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:5

    Topics: Adolescent; Antitubercular Agents; Child; Child, Preschool; Female; Humans; Infant; Levofloxacin; Male; Ofloxacin; Prospective Studies; Tuberculosis, Multidrug-Resistant

2014
The structural modeling of the interaction between levofloxacin and the Mycobacterium tuberculosis gyrase catalytic site sheds light on the mechanisms of fluoroquinolones resistant tuberculosis in Colombian clinical isolates.
    BioMed research international, 2014, Volume: 2014

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Catalytic Domain; Colombia; Crystallography, X-Ray; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Humans; Levofloxacin; Male; Molecular Docking Simulation; Mutation, Missense; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2014
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
    The Indian journal of tuberculosis, 2014, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult

2014
Limited sampling strategy and target attainment analysis for levofloxacin in patients with tuberculosis.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; Brazil; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2015
Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Recurrence; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2016
Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Latent Tuberculosis; Levofloxacin; Male; Microbial Sensitivity Tests; Micronesia; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2016
Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016, Jan-15, Volume: 1009-1010

    Topics: Antitubercular Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Fluoroquinolones; Humans; Levofloxacin; Limit of Detection; Moxifloxacin; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant

2016
Probable Levofloxacin-associated Secondary Intracranial Hypertension in a Child With Multidrug-resistant Tuberculosis.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:6

    Topics: Anti-Bacterial Agents; Child; Female; Humans; Intracranial Hypertension; Levofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2016
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
    Auris, nasus, larynx, 2017, Volume: 44, Issue:4

    Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult

2017
Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Adult; Calibration; Chromatography, High Pressure Liquid; Female; Hospitals; Humans; Levofloxacin; Male; Regression Analysis; Reproducibility of Results; Tanzania; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2017
Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, 12-01, Volume: 20, Issue:12

    Topics: Antitubercular Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2016
Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.
    The Korean journal of internal medicine, 2011, Volume: 26, Issue:2

    Topics: Adult; Antitubercular Agents; Aza Compounds; Case-Control Studies; Chi-Square Distribution; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Quinolines; Recurrence; Remission Induction; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2011
Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:12

    Topics: Adolescent; Antitubercular Agents; Aza Compounds; Child; Child, Preschool; Female; Fluoroquinolones; France; Hospitals, University; Humans; Infant; Levofloxacin; Male; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2012
Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2002, Jul-23, Volume: 167, Issue:2

    Topics: Adolescent; Adult; Anti-Infective Agents; Antitubercular Agents; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyrazinamide; Tuberculosis, Multidrug-Resistant

2002
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2002, Volume: 57, Issue:1

    Topics: Adult; Aged; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Tuberculosis, Female Genital; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2002
[A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2003, Volume: 26, Issue:8

    Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2003
Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong.
    Chest, 2003, Volume: 124, Issue:4

    Topics: Anti-Infective Agents; Female; Hong Kong; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2003
[In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Kekkaku : [Tuberculosis], 2006, Volume: 81, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Levofloxacin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2006
Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    Lancet (London, England), 2008, Mar-29, Volume: 371, Issue:9618

    Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Infant; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Population Surveillance; Rifampin; Risk Factors; South Africa; Statistics, Nonparametric; Streptococcus pneumoniae; Tuberculosis, Multidrug-Resistant; World Health Organization

2008
Levofloxacin in the treatment of drug-resistant tuberculosis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1997, Volume: 1, Issue:1

    Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Levofloxacin; Male; Ofloxacin; Radiography; Tuberculosis, Multidrug-Resistant

1997
Levofloxacin for drug-resistant Mycobacterium tuberculosis.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:2

    Topics: Adult; Anti-Infective Agents; Drug Administration Schedule; Humans; Levofloxacin; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Multidrug-Resistant

1998
Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Hea
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1999, Volume: 3, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Chi-Square Distribution; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pilot Projects; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; United States

1999
Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Chest, 2000, Volume: 117, Issue:3

    Topics: Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Hong Kong; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Recurrence; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2000
Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Feb-15, Volume: 32, Issue:4

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Humans; Injections, Spinal; Levofloxacin; Male; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant

2001
Pharmacokinetics of antituberculosis medications delivered via percutaneous gastrojejunostomy tube.
    Chest, 2002, Volume: 121, Issue:1

    Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Female; Gastrostomy; Humans; Jejunostomy; Levofloxacin; Ofloxacin; Rifampin; Saskatchewan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2002
In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2001, Volume: 84, Issue:9

    Topics: Coloring Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazines; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Xanthenes

2001